The global non-surgical bio-implants market is anticipated to excel at a robust CAGR of around 13.2% over the projection period from 2022 to 2032. The global market was set at a valuation of around USD 27.8 Billion in 2021 and is expected to reach around USD 96.0 Billion by the year 2032. The growth of the global non-surgical bio-implant market is attributed to the rising adoption of bio-implant procedures and technological advances in bioengineering technologies. These factors are expected to uplift the non-surgical bio-implants market growth over the assessment period.
An implant is known as a manufactured medical device that is carefully inserted into a human body cavity in order to replace, support or augment a biological structure that is severely damaged, missing, or already present. The prosthesis known as “bio-implants” is used to normalize a person’s physiological functions.
The physiology that is expected to be damaged, lost, or deregulated can be efficiently restored, replaced, or modulated with the help of injectable bio-implants which is a non-surgical therapy approach. The number of people with an age of over 60 and above resulted to continue the global trend of rising life expectancy and declining mortality rates. At a global level, the geriatric population is anticipated to expand at a more robust pace than any other age group, demanding an effective and safe treatment for age-related conditions. This has grabbed the attention of non–surgical bio-implants.
Key Takeaways:
- The prominent drivers responsible for the growth of the non-surgical implant market are rising concerns for chronic disorders, a high level of healthcare awareness, and a growing geriatric population. In addition to that, the surging disposable incomes of people all over the world combined with the rising application areas majorly medical and aesthetic for biomaterials used in non-surgical bio-implants will attribute the market growth.
- Moreover, the technological advances in the bio-implants sector paired with pocket-friendly prices with easy availability of bio-implants are expected to have strong growth in the market. Apart from this, the demand for bio-implants in several medical applications is fueling the market growth.
- The growth in the non-surgical bio-implant market is attributed to the heightened adoption of such remarkable bio-implant procedures resulting in its higher demand all over the world. In addition to that, rapid technological advances within the bioengineering sector are yet another prominent factor that is expected to bolster growth in the global non-surgical bio-implants market
- A manufactured medical device is known as an implant that is precisely inserted into a human body cavity with a proper medical procedure to effectively replace, support, or augment a biological structure that is missing, damaged, or already present. The help of a prosthesis also called “bio-implants” are utilized to normalize physiological functions in a human being.
- The global trend of rising life expectancy and declining mortality rates is expected to rise with the emergence of non-surgical bio-implants because the physiology that has been previously damaged can be efficiently replaced restored, replaced, or modulated with injectable bio-implants, a non-surgical therapy approach.
- At a global scale, the geriatric population is widely spreading as compared to any other age group which is predicted to augment the growth of effective and safe treatment for age-related conditions. This is expected to augment the growth of the global non-surgical bio-implants market in the near future.
Soaring Demand for Market Information: Uncover Detailed Trends and Insights in Our Report!
Competitive Landscape:
The key market players which are operating in the non-surgical implants market are anticipated to attract potential customers, especially the geriatric population within the forecast period. With rising technological advances in the non-surgical bio-implants market, prominent players are focusing on reshaping their products in order to cater to all the requirements of the patients in the future. Besides this, industry players are also focusing on expanding facilities to gain a competitive edge.
More Insights into the Non-Surgical Bio-Implants Market
Attributing to a huge number of key players and strong healthcare infrastructure, North America is anticipated to dominate the global non-surgical bio-implants market in the projection years and is expected to share the highest market attributing to the presence of dominant players in the market.
Europe is known to be the largest market for non-surgical bio-implants following North America, owing to the increasing technological advances in the region, combined with surging government support and funding and rising research and development activities.
In addition to that, because of a significant rise in the geriatric population over the past few years along with high disposable income in developing countries has resulted in bolstering the growth of the non-surgical bio-implants market in the Asia Pacific region.
Key Players:
- Albiorex International
- Moma Therapeutics, Inc.
- FibroGen, Inc.
- KYTHERA Biopharmaceuticals, Inc.
- Novatex Bioengineering SA
- Anika Therapeutics, Inc.
- Johnson & Johnson Private Limited
- Fidia Farmaceutici S.p.A.
- LCA Pharmaceuticals
- Hangzhou Gallop Biological Products Co., Ltd.
Key Segments Covered In The Non-Surgical Bio-Implants Market Industry Survey:
By Type:
- Non-surgical Bio-implants
- Viscoaugmentation Bio-implants
- Viscosupplementation Bio-implants
- Injectable Biomaterials
- Collagen
- Hyaluronan
- Biopolymers
- Hydrogels
- Hydroxyapatite
- Alloplastic Biomaterials
- Acrylic Hydrogel
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
